Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction

R Hofmann1, P Tornvall1, N Witt1

  • 1Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.

Abstract

Insights

Supplemental oxygen did not alter the inflammatory response in patients with acute myocardial infarction (AMI). This study found no significant difference in inflammatory biomarkers between AMI patients receiving oxygen versus ambient air.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation research

Background:

  • Routine oxygen therapy in normoxemic acute myocardial infarction (AMI) patients lacks strong evidence.
  • AMI triggers a systemic inflammatory response.
  • Oxygen therapy's potential to potentiate AMI-induced inflammation was investigated.

Purpose of the Study:

  • To evaluate the impact of oxygen therapy on the systemic inflammatory response in patients with acute myocardial infarction (AMI).
  • To analyze early inflammatory biomarker changes in normoxemic AMI patients receiving oxygen versus ambient air.

Main Methods:

  • Subgroup analysis of the DETO2X-AMI multicentre trial.
  • Randomized controlled trial comparing oxygen (6 L/min for 6-12 h) versus ambient air in suspected AMI patients.
  • Analysis of 92 inflammatory biomarkers using proximity extension assay in 144 confirmed AMI patients.

Main Results:

  • No significant difference in the early release of systemic inflammatory markers between oxygen and air groups.
  • Plasma troponin T levels and inflammatory biomarker changes were similar in both treatment groups.
  • Adjustments for troponin T, age, and sex did not alter the inflammatory marker similarity.

Conclusions:

  • Supplemental oxygen therapy showed no significant impact on the early systemic inflammatory response in normoxemic AMI patients.
  • The findings do not support routine oxygen use for modulating inflammation in AMI.
  • Further research may be needed to clarify oxygen's role in specific AMI subgroups.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
643
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
274
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
361